Project Details
Description
Biological & Clinical Efficacy of Subcutaneous Recombinant Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy
| Status | Finished |
|---|---|
| Effective start/end date | 11/11/02 → 11/30/09 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.